Quva

May 13, 2020

QuVa Pharma® Prepared For Increased Output Of Sterile Compounding Of Essential Medicines For COVID-19 Crisis

Dec 09, 2019

QuVa Pharma® Launches Cardioplegia Offering through a Compounding and Distribution Agreement with Hibernation Therapeutics for Adenocaine(TM) Solution

Nov 11, 2019

QuVa Pharma Announces New, Innovative Syringe Labels

Dec 13, 2018

QuVa Pharma awarded National Outsourced I.V. Admixture Services Agreement with Premier

Jul 24, 2018

Eyeing The Future, QuVa Pharma Announces Successful Capital Raise

Mar 06, 2018

QuVa Pharma in Training Program for First Responders in Terror Events

Mar 01, 2018

Endo Obtains Preliminary Injunction Against QuVa Pharma, Inc. Preventing Marketing and Release of Vasopressin Product

Jan 31, 2018

Amid Rapid Growth, QuVa Pharma Announces New Equity and Debt Funding

Sep 26, 2017

QuVa Pharma Announces FDA 503B Registration of its New Jersey Facility

Jun 20, 2017

QuVa Pharma Announces Availability of Sodium Bicarbonate Syringe